AUPH

APLS

This biopharmaceutical company develops complement-based therapies to treat autoimmune and inflammatory diseases for patients with conditions like paroxysmal nocturnal haemoglobinuria and geographic atrophy.

Alpine Immune Sciences

This biopharmaceutical company develops protein-based immunotherapies to treat autoimmune and inflammatory diseases for patients with conditions like kidney disease.

Alpine Immune

This company develops protein-based immunotherapies for patients with autoimmune and inflammatory diseases, such as IgA nephropathy and systemic lupus erythematosus.

ALMS

This biopharmaceutical company develops oral therapies to treat patients with immune-mediated diseases, neuroinflammatory conditions and neurodegenerative disorders.

Veratx

The company develops medicines for patients with autoimmune diseases, focusing on the treatment of kidney conditions such as IgA nephropathy.

Alumis

This company develops oral therapies and precision medicines for patients with immune-mediated disorders including plaque psoriasis and systemic lupus erythematosus.

Cullinan Oncology

This company develops therapies for patients living with autoimmune diseases and cancer.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.